Phio Pharmaceuticals Corp. Depreciation & Amortization 2011-2026 | PHIO

Annual Depreciation & Amortization Phio Pharmaceuticals Corp.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3 K	2 K	56 K	71 K	75 K	72 K	67 K	81 K	70 K	53 K	77 K	87 K	99 K	147 K	163 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
163 K	2 K	74.9 K

Quarterly Depreciation & Amortization Phio Pharmaceuticals Corp.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	1 K	-	-	-	16 K	-	56 K	41 K	22 K	-	55 K	36 K	18 K	-	55 K	37 K	18 K	-	51 K	36 K	18 K	-	61 K	41 K	20 K	-	48 K	27 K	11 K	-	41 K	28 K	14 K	-	60 K	41 K	21 K	-	68 K	42 K	22 K	-	78 K	53 K	26 K	-	118 K	79 K	40 K	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
118 K	1 K	40 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
AbbVie ABBV	762 M	$ 209.63	-0.71 %	$ 371 B	USA
Verastem VSTM	30 K	$ 4.99	-5.77 %	$ 346 M	USA
VistaGen Therapeutics VTGN	150 K	$ 0.57	-5.85 %	$ 17.6 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Voyager Therapeutics VYGR	4.06 M	$ 3.96	-4.24 %	$ 232 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	16 M	$ 12.36	-11.46 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	3.44 M	$ 6.39	3.06 %	$ 1.08 B	Singapore
Xenetic Biosciences XBIO	1 K	$ 2.78	-0.71 %	$ 4.73 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
XBiotech XBIT	1.69 M	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	2.56 M	$ 54.44	-1.96 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	1.31 M	$ 5.41	-2.87 %	$ 868 M	USA
X4 Pharmaceuticals XFOR	1.28 M	$ 4.07	-5.57 %	$ 172 M	USA
Xencor XNCR	10.5 M	$ 11.4	-7.43 %	$ 846 M	USA
XOMA Corporation XOMA	2.96 M	$ 29.93	-1.97 %	$ 362 M	USA
22nd Century Group XXII	479 K	$ 2.41	-18.03 %	$ 444 K	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 1.06	-2.75 %	$ 21.7 M	Israel
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA